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Abstract
Background: There are hardly any studies carried out in Pakistan on the usage of benzodiazepines at the level of
community. This research was aimed to determine the frequency of benzodiazepine use, along with its
associations with socio-demographic and clinical characteristics among community dwelling adults, residing in two
urban settlements of Karachi, Pakistan.
Methods: We performed a cross sectional study from August 2008 to December 2009, in 2 areas of Karachi,
namely Garden and Sultanabad. We followed the systematic sampling strategy to randomly select the households,
with an adult of either sex and of age 18 years or more. Data collection was carried out through interview, using a
pre-tested questionnaire, with items on socio-demographic position, medical history and benzodiazepine use.
Student’s t-test and c2 test was employed to determine the associations between socio-demographic and clinical
characteristics, and their relationship with benzodiazepine use was determined using applied logistic regression.
Results: The overall percentage of benzodiazepine consumption was estimated to be 14%. There were significantly
more benzodiazepine users in the peri-urban Sultanabad community to the urban community of Garden (p-value
= 0.001). The mean age (± SD) for users was 51.3 (± 15.6) years compared to 37.1 (± 14.4) years among non-users.
Bromazepam was the most widely used benzodiazepine (29%); followed by diazepam, with a median duration on
primary use being 144 weeks (IQR = 48-240). The adjusted logistic regression model revealed that increasing age,
location, female sex, unemployment and psychiatric consultation were associated with increased likelihood of
benzodiazepine use.
Conclusion: We believe the unregulated over-the-counter sales of benzodiazepines and social conditions might be
playing a role in this high consumption of benzodiazepines in the community.

Background
After the discovery of chlordiazepoxide in 1957, benzodiazepines are among the most widely used drugs in the
general population [1-6]. These were generally prescribed to combat anxiety and insomnia but over time
these are now being used for a wide array of psychiatric
and non-psychiatric illnesses, in view of their sedative,
anti-convulsant and muscle relaxing properties [1,7-9].
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Despite their therapeutic uses, tendency remains for
benzodiazepine abuse among the general population.
Several adverse reactions have been reported in studies
which include cognitive decline, motor disturbances,
unwanted sedation and reduced coordination [10,11]. In
addition, benzodiazepines pose a risk of dependence
which may become as high as 45% after 6 months of
continuous use [12,13]. In view of this, benzodiazepine
sale and usage have been regulated in many developed
countries [14]. However, this is not commonly practiced
in most developing countries, including Pakistan, where
practically these can be purchased over-the-counter,
with considerable ease [9,15,16].
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Keeping in view the various definitions of benzodiazepine use, types of population and settings, and periods
of observation, estimates reveal that prevalence of benzodiazepine consumption may range from 2% to 17%
[17,18]. A recent summary from USA reports a 12month prevalence of use of benzodiazepines (as tranquilizers) as 8.6% [19]. In a local study, the percent use of
benzodiazepines among in-patients in a tertiary care
hospital in Pakistan is reported to be 21.2% [16]. In
another recent study on outpatients in 2 tertiary care
hospitals, use of benzodiazepines is reported to be
around 45% [20].
There are hardly any studies in this region to estimate
the frequency of benzodiazepine use at the level of community. Most studies in the Western countries have
been conducted on elderly populations (more than 65
years) where the prevalence estimates have been found
to be 9.9% in USA, 20% in Canada and 31.9% in France
[21-23]. From a study in Brazil, a 22% frequency of benzodiazepine use has been reported among elderly persons living in the community [24,25]. Few studies have
been carried out in the general population even in the
developed countries. For example studies from Boston,
France and Lebanon benzodiazepine usage has been
reported to be 7.3%, 7.5% and 9.9%, respectively [26-28].
In another study a prevalence estimate of 9.2% benzodiazepine usage was reported from a combined population of 6 European countries [29]. Such estimates are
not available for a developing country like Pakistan,
where we might expect these to be much higher owing
to easy accessibility of these drugs, without a
prescription.
Risk factors, common to benzodiazepine use are
increasing age and female gender, and have been
reported in most studies, regardless of the population
[16,20,22,24,25,27,28,30]. Other reported associations
are cigarette smoking, marital status, education and
occupation [16,27,28]. The objective of the present
study was to estimate the frequency of benzodiazepine
use among 2 populations in Karachi, Pakistan, and to
determine its associations with related socio-demographic and clinical characteristics which are unique to
these populations.

Methods
Study Design and settings

A cross sectional study was conducted from August
2008 to December 2009. Two sites from the metropolitan city of Karachi, Pakistan were selected for this
research, namely Sultanabad and Garden, as community
health services were provided to these areas by the Aga
Khan University. Moreover, there were differences in
the socio-economic conditions in these 2 areas.
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Sultanabad is a relatively low income squatter settlement situated in the district East of Karachi. Mainly
inhabited by the Pashtoon and Punjabi migrants from
northern Pakistan, it has a population of more than
53000 people. Garden is one of the neighborhoods adjacent to the Central district of Karachi. Estimated population is more than 65000 and majority of the people
belong to a relatively affluent group. Due to these reasons, these places were well suited to have a comparative assessment of benzodiazepine use among the
community people.
Sampling strategy

We used a systematic random sampling approach to
randomly select a representative sample from each of
the study sites. About 4000 households from Sultanabad
and about 5000 households from Garden were available
for this study. Employing the strategy, every 10th household was approached for the interview starting from a
random pick using random number tables, from the
first 10 households. Our inclusion criteria were to select
an adult of age 18 years and above of either sex. If the
subject from a household was found unwilling to participate in the study, the adjacent house was approached.
Data Collection

Data were collected using a specially designed questionnaire, similar to the questionnaire used in a previously
published study (20). The participation by the subjects
was voluntary. At first they were inquired about their
demographic and socioeconomic position such as age,
gender, marital status, ethnicity, education and occupation. Following that, questions related to any medical
and psychiatric ailments, any consultations and if any
medications used were asked. If benzodiazepines were
found in use, the subjects were asked whether it was self
medication or prescribed. In addition, the duration, frequency, dose and route of administration were noted.
Equivalent doses were later calculated using the Maudsley Prescribing Guidelines [31].
Statistical Analysis

Analyses were performed using the Statistical Package
for Social Sciences for Windows version 17 (SPSS Inc.,
Chicago, IL., USA). Frequencies were calculated for all
characteristics and expressed in either means (± SD) or
medians (IQR) for quantitative variables and percentages
for categorical characteristics. Chi-square (c2) of independence was used to determine significant associations
between categorical variables, whereas t-test was
employed to assess the differences among quantitative
characteristics. Applied logistic regression was used to
determine the factors predicting the likelihood of
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benzodiazepine use. P-value, if less than 0.05 was considered significant.
Ethical approval

Informed consent was obtained before interviewing the
subjects for the study. They were told that their participation was voluntary and they were at liberty to refuse
if they wished so. The study was approved by the Ethics
Review Committee (ERC) of the Aga Khan University.

Results
Tables 1 and 2 summarize the socio-demographic and
clinical characteristics with respect to benzodiazepine
usage in the overall sample and at the 2 sites, respectively. A total of 749 subjects were recruited, out of
which 102 (14%) were currently using benzodiazepines. Benzodiazepine users was older compared to
the non-users (mean age 51.3 ± 15.6 years vs. 37.1 ±
14.4 years; t = -9.1; df = 746; p-value < 0.001). Significantly more females compared to males were using
benzodiazepines (17% vs. 9%; Wald c 2 = 8.1; df = 1;
p-value = 0.004).
The mean ages between male and female benzodiazepine users were not significantly different (mean age
51.6 ± 14.2 years vs. 50.8 ± 16.2 years; t = 0.24; df = 93;
p-value = 0.81). Majority of the people in the sample
were married (67%), and 18% of them were consuming
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benzodiazepines. Benzodiazepine use was highest (43%)
in the category of uneducated persons. In terms of frequency of benzodiazepine use in the 2 communities,
there is significantly greater proportion of users in the
peri-urban area of Sultanabad, compared to Garden
(Table 1). Moreover in this area, the people were relatively less educated compared to the people in Garden
area (Table 2).
In these 2 samples, 16% had a history for coronary
artery disease (CAD), while diabetes mellitus was
reported to be 7%. A total of 28 (4%) subjects had
reported to be suffering from depression, from which
21 (75%) were using benzodiazepines. Among the
recruited subjects, 36 reported to have seen a psychiatrist before the interview. From those, 22 were using
benzodiazepines.
Data on users

The most used benzodiazepine was bromazepam (29%),
followed by diazepam (26%), alprazolam (24%) and lorazepam (24%). The median duration of primary use was
144 weeks (IQR = 48-240)). About 67% reported to have
been using benzodiazepines continuously; 46% of them
reported to have been using these daily, and 21% were
using it on a weekly basis. We estimated the median
diazepam equivalent dose to be 10 mg (IQR = 5-25). A
small proportion had been using on the advice of a

Table 1 Characteristics of the study population with respect to benzodiazepine use (n = 749)
Characteristics
Age (means ± SD)
Location
Gender
Marital Status
Education

Occupation

Psychiatric consult

Total

Benzodiazepine users

Wald c2

df

P-value

OR (95% CI)

38.96 ± 15.33

51.30 ± 15.58

62.7

1

0.001

1.06 (1.04-1.07)

15.9

1

0.001

2.46 (1.58-3.84)

8.4

1

0.004

1.93 (1.24-3.01)

20.5

1

0.001

4.22 (2.26-7.87)

Garden, n (%)

383

33 (9)

Sultanabad, n (%)

366

69 (19)

Male, n (%)

349

33 (9)

Female, n (%)

399

67 (17)

Unmarried, n (%)

249

12 (5)

Married, n (%)

500

88 (18)

1
1
1

Post-graduation, n (%)

71

5 (7)

Graduation, n (%)

213

17 (8)

19.5

1

0.001

1.15 (0.41-3.22)

Intermediate, n (%)

171

13 (8)

6.3

1

0.01

1.09 (0.37-3.17)

Secondary, n (%)

176

21 (12)

1.3

1

0.26

1.79 (0.65-4.94)

Primary, n (%)

35

9 (26)

0.02

1

0.9

4.57 (1.40-14.93)

None, n (%)

72

31 (43)

0.07

1

0.8

9.98 (3.59-27.73)

Student, n (%)

98

4 (4)

Salaried workers, n (%)

128

17 (13)

5

1

0.03

3.60 (1.17-11.07)

Housewife, n (%)

195

44 (23)

12.8

1

0.001

6.85 (2.38-19.68)

Retired, n (%)

31

9 (29)

12.3

1

0.001

9.61 (2.71-34.10)

Labor, n (%)

197

14 (7)

1

1

0.313

1.80 (0.58-5.61)

Business, n (%)

81

6 (7)

0.9

1

0.342

1.88 (0.52-6.91)

Unemployed, n (%)

10

5 (50)

15.1

1

0.001

23.50 (4.78-115.59)

No, n (%)

703

75 (11)

Yes, n (%)

36

22 (61)

50.4

1

0.001

13.16 (6.46-26.81)

SD = Standard deviation; df = degrees of freedom; OR = Odds ratio; CI = Confidence interval

1

1

1
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Table 2 Characteristics of the study population with respect to location
Characteristics
Age (means ± SD)

Sultanabad (n = 366)

Garden (n = 383)

Test

df

38.09 ± 15.3

39.81 ± 15.3

t = -1.53

743

0.13

c2 = 3.2

1

0.08

c2 = 4.4

1

0.04

c2 = 31.9

5

0.01

c2 = 34.5

6

0.01

c2 = 0.82

1

0.36

Gender
Male, n (%)

157 (43)

190 (50)

Female, n (%)

206 (57)

192 (50)

Marital Status
Unmarried, n (%)

134 (38)

113 (30)

Married, n (%)

230 (62)

269 (70)

Education
Post-graduation, n (%)

32 (9)

P-value

38 (10)

Graduation, n (%)

114 (32)

98 (26)

Intermediate, n (%)

67 (19)

104 (27)

Secondary, n (%)

70 (20)

106 (28)

Primary, n (%)

28 (8)

7 (2)

None, n (%)

43 (12)

28 (7)

Occupation
Student, n (%)

50 (14)

47 (12)

Salaried workers, n (%)

90 (25)

38 (10)

Housewife, n (%)

78 (22)

117 (31)

Retired, n (%)

12 (3)

19 (5)

Labor, n (%)

93 (26)

104 (27)

Business, n (%)

33 (9)

48 (13)

Unemployed, n (%)

3 (1)

6 (2)

No, n (%)

346 (96)

354 (94)

Yes, n (%)

15 (4)

21 (6)

Psychiatric consult

SD = standard deviation
df = degrees of freedom

psychiatrist (3%), while majority had been using these
upon either the prescription of local practitioners (40%)
or self (24%). Only 22% of the users were taking these
for genuine complaints, especially depression, while
most were using for minor complaints such as insomnia
(21%) and anxiety (8%).
Using applied logistic regression, crude estimates for
odds ratios for educational categories revealed that the
odds of benzodiazepine use were more among less educated subjects (Table 1). In the category of occupation,
crude estimates revealed the likelihood of greater use
among the unemployed, retired, housewives and salaried
worker categories (Table 1). In the adjusted model,
increasing age, location of residence, female sex, unemployment and psychiatric consult were associated with
increase in odds of benzodiazepine use in the community (Table 3).

Discussion
The purpose of this study was to estimate the frequency
of benzodiazepine use among the 2 local communities
in Karachi, Pakistan. To the best of our knowledge, no
study of this kind has been conducted in this region.

Table 3 Adjusted odds ratios (with 95% CI) computed
using multiple logistic regression
Characteristics

Wald
c2

df

Pvalue

Adjusted OR
(95% CI)

29.9

1

0.001

1.06 (1.04-1.09)

25.3

1

0.001

4.49 (2.50-8.10)

Female

4.0

1

0.04

2.20 (1.02-4.75)

Unmarried
Married

3.0

1

0.08

1
2.39 (0.89-6.40)

0.03

1

0.86

0.89 (0.20-4.08)

Age
Location

Garden
Sultanabad

Gender
Marital status
Occupation

Male

1

Student
Professional

Psychiatric
consult

1

1

Housewife

0.36

1

0.55

0.61 (0.12-3.18)

Retired

0.25

1

0.62

1.66 (0.24-11.67)

Labor

0.13

1

0.71

0.68 (0.14-3.36)

Business
Unemployed

0.93
4.9

1
1

0.33
0.03

0.39 (0.06-2.78)
14.50 (1.38-151.87)

No
Yes

1
40.8

1

0.001

18.9 (7.68-46.65)

df = degrees of freedom; OR = Odds ratio; CI = Confidence interval
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The proportionate benzodiazepine use among the studied sample was 14%; higher than that reported in Boston, France and Lebanon [26-28]. One reason for this
high estimate could be the unregulated availability of
benzodiazepines in the local market. Additionally, in
presence of co-morbidities such as hypertension, general
practitioners do prescribe benzodiazepines for better
control and relief. Our study showed that about 40% of
cases with co-morbidities had been using benzodiazepines on the advice of general practitioners. The
reported high estimates point to the need to caution
both doctors and patients on the associated risk of
dependence, and to regulate the accessibility of benzodiazepines in this country.
Benzodiazepine users in our sample were mostly
elderly females. This finding is quite consistent with the
findings by other researchers [22,24,27-29,32-36]. Older
people are more likely to be using benzodiazepines for
relieving insomnia and anxiety related to isolation,
depression and medical ailments [37,38]. Reports also
suggest that anxiety occurs more in females compared
to males [36,39]. Moreover, as females tend to live
longer than males, the psychological problems are more
likely to be encountered by them [40]. Another important fact is that females, in general, are more cooperative
in explaining their health problems and thus are relatively more compliant towards the prescribed medications [40,41].
Bromazepam was found to be the most used benzodiazepine in the study settings. Similar results have also
been reported in community based studies in Brazil
[24,42]. The second most commonly used benzodiazepine was diazepam. The median duration of primary use
in our study was 144 weeks, whereas the recommended
duration by clinicians/psychiatrists should not be more
than 4 weeks [43]. According to literature, caution
should be exercised while prescribing benzodiazepines;
as in case of those with shorter half lives and high
potency, there is a tendency for therapeutic dose dependence; while those with longer half lives are usually
associated with impaired cognition and prolonged sedation, as the drug may get accumulated in the body of
the individual [44-47]. In Pakistan, the situation is quite
serious due to the easier access of these drugs over-thecounter. This may pose a risk to the general population.
In this research, we found the use of benzodiazepines
more among the less educated class of subjects. Other
researchers have also shown the maximum use of benzodiazepines among the less educated individuals
[32,36,48]. Awareness regarding the risks associated with
benzodiazepine use among the educated individuals
could be a plausible reason for restricted use of these
drugs. In our study, this was not significant in the multivariable model, perhaps due to stratification of the
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educational categories. The adjusted regression model
showed that the unemployed persons were more
inclined to use benzodiazepines. Similar findings have
been also reported by other investigators, such as Lagnaoui et al. who have indicated higher rates of benzodiazepine use among jobless individuals [27].
Our results should be seen within the context of certain limitations of this research. This study being the
first of its kind in this country, describes the “current”
status of benzodiazepine use. Another limitation could
be fewer subjects in the occupational category for
unemployment (1.3%); which, though significant, we
believe could be “under-reporting.” In low income communities a reasonable proportion of population might
have been working for just 1-2 days in a week and considering themselves as employed. We presented the
results for 2 different communities in Karachi and these
2 sites would not be representative of the whole city of
18 million people. Nonetheless, we believe the results to
be fairly representative of the concerned populations
owing to the systematic random sampling employed in
the research and a reasonable sample size. The findings
we present are consistent with what has been reported
by other researchers on Western populations. More surveys at multiple communities would provide a deeper
insight into the prolonged use of benzodiazepines and
various factors governing its usage, in Pakistan. This
would provide the necessary sensitization of the medical
community and measures to be taken to effectively control benzodiazepine use in the developing world.

Conclusion
The proportion of benzodiazepine use in the 2 communities of Karachi, Pakistan is relatively higher than that
reported in the developed countries. It is a matter of
concern in view of the associated adverse events and the
prevalent physical and psychological conditions in developing countries. Further research at the national level
would be imperative to provide a deeper insight into the
problem of prolonged benzodiazepine use especially
without a proper consult of a psychiatrist (only 4.7% in
the study sample had been seen by a psychiatrist and
among the benzodiazepine users nearly 40% had been
using it without a psychiatric consult) and its associated
mental health issues. Sensitization of the medical community and the masses to this growing problem of benzodiazepine use and associated risks is necessary to
control it in the developing societies.
Author details
1
Department of Pediatrics & Child Health, Aga Khan University, Stadium
Road, Karachi, Pakistan. 2Department of Psychiatry, Aga Khan University,
Stadium Road, Karachi, Pakistan. 3School of Nursing, Aga Khan University,
Stadium Road, Karachi, Pakistan.

Iqbal et al. Substance Abuse Treatment, Prevention, and Policy 2011, 6:19
http://www.substanceabusepolicy.com/content/6/1/19

Authors’ contributions
SA, SPI and RAMK were involved in the conceptualization and
implementation of the research. They were also involved in data
interpretation and write up of the manuscript. SPI provided epidemiological
support and performed the statistical analyses. SF, YP and AT were involved
in implementation of the research and data interpretation. MZ was involved
in data entry, cleaning and interpretation. All authors have read and
approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 9 February 2011 Accepted: 1 August 2011
Published: 1 August 2011
References
1. Balter MB, Levine J, Manheimer DI: Cross-national study of the extent of
anti-anxiety-sedative drug use. N Engl J Med 1974, 290(14):769-774.
2. Edwards C, Bushnell JL, Ashton CH, Rawlins MD: Hospital prescribing and
usage of hypnotics and anxiolytics. Br J Clin Pharmacol 1991,
31(2):190-192.
3. Mellinger GD, Balter MB, Uhlenhuth EH: Prevalence and correlates of the
long-term regular use of anxiolytics. JAMA 1984, 251(3):375-379.
4. Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH: Prevalence,
frequency, and duration of hypnotic drug use among the elderly living
at home. Br Med J (Clin Res Ed) 1988, 296(6622):601-602.
5. Olfson M, Pincus HA: Use of benzodiazepines in the community. Arch
Intern Med 1994, 154(11):1235-1240.
6. Uchibayashi M: [Leo Sternbach, an inventor of benzodiazepines].
Yakugaku Zasshi 2007, 127(1):217-224.
7. Ashton H: Guidelines for the rational use of benzodiazepines. When and
what to use. Drugs 1994, 48(1):25-40.
8. de las Cuevas C, Sanz EJ: Controversial issues associated with the
prescription of benzodiazepines by general practitioners and
psychiatrists. Med Sci Monit 2004, 10(7):CR288-293.
9. Kapczinski F, Amaral OB, Madruga M, Quevedo J, Busnello JV, de Lima MS:
Use and misuse of benzodiazepines in Brazil: a review. Subst Use Misuse
2001, 36(8):1053-1069.
10. Rickels K, Lucki I, Schweizer E, Garcia-Espana F, Case WG: Psychomotor
performance of long-term benzodiazepine users before, during, and
after benzodiazepine discontinuation. J Clin Psychopharmacol 1999,
19(2):107-113.
11. Salzman C: Issues and controversies regarding benzodiazepine use. NIDA
Res Monogr 1993, 131:68-88.
12. Petursson H, Lader MH: Withdrawal from long-term benzodiazepine
treatment. Br Med J (Clin Res Ed) 1981, 283(6292):643-645.
13. Tyrer P, Rutherford D, Huggett T: Benzodiazepine withdrawal symptoms
and propranolol. Lancet 1981, 1(8219):520-522.
14. Lader M: Benzodiazepine dependence. Prog Neuropsychopharmacol Biol
Psychiatry 1984, 8(1):85-95.
15. Khan MM, Reza H: Benzodiazepine self-poisoning in Pakistan:
implications for prevention and harm reduction. J Pak Med Assoc 1998,
48(10):293-295.
16. Khawaja MR, Majeed A, Malik F, Merchant KA, Maqsood M, Malik R,
Mazahir S, Naqvi H: Prescription pattern of benzodiazepines for
inpatients at a tertiary care university hospital in Pakistan. J Pak Med
Assoc 2005, 55(6):259-263.
17. Bonsack C, Camus D, Kaufmann N, Aubert AC, Besson J, Baumann P,
Borgeat F, Gillet M, Eap CB: Prevalence of substance use in a Swiss
psychiatric hospital: interview reports and urine screening. Addict Behav
2006, 31(7):1252-1258.
18. Zandstra SM, Furer JW, van de Lisdonk EH, van’t HM, Bor JH, van Weel C,
Zitman FG: Different study criteria affect the prevalence of
benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002, 37(3):139-144.
19. Substance Abuse and Mental Health Services Administration: Results from
the 2009 National Survey on Drug Use and Health: Volume I. Summary
of National Findings (Office of Applied Studies, NSDUH Series H-38A,
HHS Publication No. SMA 10-4856 Findings). Rockville, MD 2010.
20. Ahmer S, Salamat S, Khan RA, Iqbal SP, Haider II, Khan AS, Zafar M: Pattern
of benzodiazepine use in psychiatric outpatients in Pakistan: a crosssectional survey. Clin Pract Epidemiol Ment Health 2009, 5:9.

Page 6 of 7

21. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B: Benzodiazepine
use in an elderly community-dwelling population. Characteristics of
users and factors associated with subsequent use. Eur J Clin Pharmacol
2001, 57(5):419-425.
22. Gleason PP, Schulz R, Smith NL, Newsom JT, Kroboth PD, Kroboth FJ,
Psaty BM: Correlates and prevalence of benzodiazepine use in
community-dwelling elderly. J Gen Intern Med 1998, 13(4):243-250.
23. Mayer-Oakes SA, Kelman G, Beers MH, De Jong F, Matthias R, Atchison KA,
Lubben JE, Schweitzer SO: Benzodiazepine use in older, communitydwelling southern Californians: prevalence and clinical correlates. Ann
Pharmacother 1993, 27(4):416-421.
24. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E:
Prevalence and sociodemographic characteristics associated with
benzodiazepines use among community dwelling older adults: the
Bambui Health and Aging Study (BHAS). Rev Bras Psiquiatr 2008,
30(1):7-11.
25. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E: A
population based study on health conditions associated with the use of
benzodiazepines among older adults (The Bambui Health and Aging
Study). Cad Saude Publica 2009, 25(3):605-612.
26. Hall SA, Chiu GR, Kaufman DW, Kelly JP, Link CL, Kupelian V, McKinlay JB:
General exposures to prescription medications by race/ethnicity in a
population-based sample: results from the Boston Area Community
Health Survey. Pharmacoepidemiol Drug Saf 2010, 19(4):384-392.
27. Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Begaud B, Verdoux H,
Moore N: Patterns and correlates of benzodiazepine use in the French
general population. Eur J Clin Pharmacol 2004, 60(7):523-529.
28. Naja WJ, Pelissolo A, Haddad RS, Baddoura R, Baddoura C: A general
population survey on patterns of benzodiazepine use and dependence
in Lebanon. Acta Psychiatr Scand 2000, 102(6):429-431.
29. Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I,
Kovess V, Haro JM, Alonso J: Clinical factors influencing the prescription
of antidepressants and benzodiazepines: results from the European
study of the epidemiology of mental disorders (ESEMeD). J Affect Disord
2008, 110(1-2):84-93.
30. Schmidt LG, Grohmann R, Muller-Oerlinghausen B, Otto M, Ruther E, Wolf B:
Prevalence of benzodiazepine abuse and dependence in psychiatric inpatients with different nosology. An assessment of hospital-based drug
surveillance data. Br J Psychiatry 1989, 154:839-843.
31. Taylor D, Paton C, Kerwin R: The Maudsly 2005-2006 Prescribing Guidelines. 8
edition. Taylor & Francis. London; 2005.
32. Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W,
Beekman AT: Ten-year trends in benzodiazepine use in the Dutch
population. Soc Psychiatry Psychiatr Epidemiol 2011.
33. Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA: Benzodiazepine
prescribing to the Swiss adult population: results from a national survey
of community pharmacies. Int Clin Psychopharmacol 2007, 22(5):292-298.
34. Lyndon RW, Russell JD: Benzodiazepine use in a rural general practice
population. Aust N Z J Psychiatry 1988, 22(3):293-298.
35. Magrini N, Vaccheri A, Parma E, D’Alessandro R, Bottoni A, Occhionero M,
Montanaro N: Use of benzodiazepines in the Italian general population:
prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol
1996, 50(1-2):19-25.
36. Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K:
Benzodiazepine anti-anxiety agents: prevalence and correlates of use in
a southern community. Am J Public Health 1991, 81(5):592-596.
37. Fernandez L, Cassagne-Pinel C: [Benzodiazepine addiction and symptoms
of anxiety and depression in elderly subjects]. Encephale 2001,
27(5):459-474.
38. Llorente MD, David D, Golden AG, Silverman MA: Defining patterns of
benzodiazepine use in older adults. J Geriatr Psychiatry Neurol 2000,
13(3):150-160.
39. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, Kahn K,
Merrick N, Solomon DH: Variations in the use of medical and surgical
services by the Medicare population. N Engl J Med 1986, 314(5):285-290.
40. Voyer P, Cohen D, Lauzon S, Collin J: Factors associated with psychotropic
drug use among community-dwelling older persons: A review of
empirical studies. BMC Nurs 2004, 3(1):3.
41. Jorm AF, Grayson D, Creasey H, Waite L, Broe GA: Long-term
benzodiazepine use by elderly people living in the community. Aust N Z
J Public Health 2000, 24(1):7-10.

Iqbal et al. Substance Abuse Treatment, Prevention, and Policy 2011, 6:19
http://www.substanceabusepolicy.com/content/6/1/19

Page 7 of 7

42. Huf G, Lopes C, Rozenfeld S: [Long-term benzodiazepine use in women
at a daycare center for older people]. Cad Saude Publica 2000,
16(2):351-362.
43. American Psychiatric Association: Benzodiazepine dependence, toxicity
and abuse. A task force report of the American Psychiatric Association
Washington, D.C. American Psychiatric Association; 1990.
44. Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ: The
acute and chronic performance effects of alprazolam and lorazepam in
the elderly: relationship to duration of treatment and self-rated
sedation. Psychopharmacol Bull 1998, 34(2):139-153.
45. Salzman C: The APA Task Force report on benzodiazepine dependence,
toxicity, and abuse. Am J Psychiatry 1991, 148(2):151-152.
46. Cook PJ: Benzodiazepine hypnotics in the elderly. Acta Psychiatr Scand
Suppl 1986, 332:149-158.
47. Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D: Is there a
rationale for prescription of benzodiazepines in the elderly? Review of
the literature. Acta Clin Belg 2003, 58(1):27-36.
48. Esposito E, Barbui C, Patten SB: Patterns of benzodiazepine use in a
Canadian population sample. Epidemiol Psichiatr Soc 2009, 18(3):248-254.
doi:10.1186/1747-597X-6-19
Cite this article as: Iqbal et al.: Benzodiazepine use among adults
residing in the urban settlements of Karachi, Pakistan: A cross sectional
study. Substance Abuse Treatment, Prevention, and Policy 2011 6:19.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

